Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
Metrics to compare | ERIS | Peers Peers - average of corresponding metrics from companies closely matching ERIS: MOREPENLAB, TORNTPHARM, INDOCO, SIGACHI, EMCURE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipERISPeersSector |
---|---|---|---|---|
P/E Ratio | 57.2x | 38.2x | −0.6x | |
PEG Ratio | −5.74 | 0.21 | 0.00 | |
Price/Book | 7.2x | 4.3x | 2.6x | |
Price / LTM Sales | 8.0x | 4.8x | 3.2x | |
Upside (Analyst Target) | 1.5% | 3.8% | 49.4% | |
Fair Value Upside | Unlock | −17.4% | 7.8% | Unlock |